Coxibs—Beyond the GI Tract
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 25 (2), 41-49
- https://doi.org/10.1016/s0885-3924(02)00630-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cardiovascular Thrombotic Events in Controlled, Clinical Trials of RofecoxibCirculation, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- The macula densa is worth its saltJournal of Clinical Investigation, 1999
- A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritisGastroenterology, 1999
- Influence of non-steroidal anti-inflammatory drugs on renal function and 24 h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patientsJournal Of Hypertension, 1995
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney FunctionThe Journal of Clinical Pharmacology, 1991
- Propranolol increases prostacyclin synthesis in patients with essential hypertension.Hypertension, 1988
- RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2The Lancet, 1988